1.

Additional file 1 of Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

2.

Additional file 1 of Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

3.

Additional file 1 of Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

1.

Additional file 2 of Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

2.

Additional file 2 of Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

3.

Additional file 2 of Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

1.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

2.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

3.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach ...

1.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach

2.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach

3.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach

4.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach

5.

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach

1.

Ten years countdown to hepatitis C elimination in Belgium : a mathematical modeling approach

1.

Hepatitis E virus in pork meat products and exposure assessment in Belgium

1.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

2.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

3.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

4.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

5.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

6.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

7.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

8.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

9.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3

1.

Analyses of clinical and biological data for French and Belgian immunocompetent patients infected with hepatitis E virus genotypes 4 and 3

1.

Analyses of Clinical and Biological Data for French and Belgian Immunocompetent Patients Infected With Hepatitis E Virus Genotypes 4 and 3.

1.

Low hepatitis C prevalence in Belgium : implications for treatment reimbursement and scale up